Novel SN38 Derivative-Based Liposome as Anticancer Prodrug: An in Vitro and in Vivo Study

International Journal of Nanomedicine - New Zealand
doi 10.2147/ijn.s187906
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

The Novel Melphalan Prodrug J1 Inhibits Neuroblastoma Growth in Vitro and in Vivo

Molecular Cancer Therapeutics
Cancer ResearchOncology
2007English

Liposomal Codelivery of an SN38 Prodrug and a Survivin siRNA for Tumor Therapy

International Journal of Nanomedicine
Organic ChemistryBiophysicsBiomaterialsPharmaceutical ScienceMedicineBioengineeringDrug DiscoveryNanoscienceNanotechnology
2018English

In-Vivo Study on Organometallic Compounds as Anticancer Agents

Asian Journal of Research in Biochemistry
2019English

A Novel Taspine Derivative Suppresses Human Liver Tumor Growth and Invasion in Vitro and in Vivo

Oncology Letters
Cancer ResearchOncology
2013English

A Novel Polycaprolactone/Carbon Nanofiber Composite as a Conductive Neural Guidance Channel: An in Vitro and in Vivo Study

Progress in Biomaterials
2019English

In Vitro and in Vivo Evaluation of Macromolecular Prodrug GC-FUA Based Nanoparticle for Hepatocellular Carcinoma Chemotherapy

Drug Delivery
MedicinePharmaceutical Science
2017English

A Photocleavable Amphiphilic Prodrug Self-Assembled Nanoparticles With Effective Anticancer Activity in Vitro

Nanomaterials
Materials ScienceChemical Engineering
2019English

Anticancer Gold N-Heterocyclic Carbene Complexes: A Comparative in Vitro and Ex Vivo Study

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2017English

NAHA, a Novel Hydroxamic Acid-Derivative, Inhibits Growth and Angiogenesis of Breast Cancer in Vitro and in Vivo

PLoS ONE
Multidisciplinary
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy